Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Pietro Lampertico, Kosh Agarwal, Thomas Berg et al. · Journal of Hepatology · 2017 · 5.4K citations

Pharmacy, Infectious Diseases, Internal Medicine +16

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Norah A. Terrault, Anna S. Lok, Brian J. McMahon et al. · Hepatology · 2018 · 4.3K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

An Algorithm for the Grading of Activity in Chronic Hepatitis C

Pierre Bédossa, Thierry Poynard · Hepatology · 1996 · 4K citations · Full text

Medicine, Internal Medicine, Pathology +17

Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level

Chien‐Jen Chen · JAMA · 2006 · 3.1K citations

Medicine, Internal Medicine, Oncology +16

Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

Yun‐Fan Liaw, Joseph J.�Y. Sung, Wan Cheng Chow et al. · New England Journal of Medicine · 2004 · 2.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17